Thermo Fisher adds new LC-MS systems for clinical diagnostics

Skip to Navigation

News

  • Published: Apr 3, 2019
  • Source: Thermo Fisher Scientific
  • Suppliers: Thermo Fisher Scientific
  • Channels: HPLC / Base Peak
thumbnail image: Thermo Fisher adds new LC-MS systems for clinical diagnostics

Thermo Scientific Vanquish MD HPLC system

Thermo Scientific Vanquish MD HPLC system.

Thermo Fisher Scientific has expanded its portfolio of analytical instruments for clinical diagnostic laboratories with the addition of three systems listed as Class I medical devices with the US Food and Drug Administration. The portfolio now offers clinical diagnostic laboratories access to additional instruments that can be used to develop sensitive, robust and reliable laboratory developed tests (LDTs).

The Thermo Scientific Medical Device (MD) portfolio of liquid chromatography-mass spectrometry (LC-MS) systems now include the Thermo Scientific Vanquish MD High Performance Liquid Chromatography (HPLC) system, the Thermo Scientific TSQ Altis MD Series mass spectrometer and the Thermo Scientific Quantis MD Series mass spectrometer. The new systems join the existing Prelude MD HPLC and Prelude LX-4 MD HPLC systems to form a more complete MD portfolio of analytical solutions that can allow diagnostic laboratories to achieve sensitivity, safeguard robustness and improve reliability. In addition, the enhanced product portfolio is designed to increase throughput of clinical diagnostic assays for the detection of small to large molecules within complex biological matrices.

"Clinical laboratories are under pressure to develop and optimize sensitive and reliable laboratory developed tests that play an essential role in the diagnosis and monitoring of acute and chronic diseases," said Bradley Hart, senior director, clinical research, chromatography and mass spectrometry, Thermo Fisher Scientific. "With the new MD portfolio of Class I medical devices with the US FDA, scientists in clinical diagnostic laboratories can now choose from a unique portfolio of liquid chromatography and mass spectrometry platforms to develop and optimize assays essential for clinical decision-making."

Designed to bring high-quality analytical performance to clinical diagnostic laboratories, the TSQ Altis MD Series MS and TSQ Quantis MD series mass spectrometers enable high robustness and sensitivity for analysis and quantitation of complex biological samples. The Vanquish MD HPLC system offers separation capabilities that can enhance the resolution of analytes.

The MD portfolio is powered by Thermo Scientific TraceFinder LDT 1.0 Software, providing a regulatory compliance management software solution for managing clinical diagnostic workflows. In addition, Thermo Fisher Scientific has collaborated with BYG Informatique on a middleware solution that can enable seamless integration of data from TraceFinder LDT 1.0 to most laboratory information management systems (LIMS) used by diagnostic laboratories.

Social Links

Share This Links

Bookmark and Share

Microsites

Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in separation science? Visit our sister site separationsNOW.com

Copyright © 2019 John Wiley & Sons, Inc. All Rights Reserved